found that hypoglycemia was less common with liraglutide 3.0 mg than with placebo in individuals with overweight or obesity and insulin-treated type 2 diabetes [43]
Data Sources and Inclusion Parameters The PHARMO Data Network was accessed to obtain patient healthcare data
Muscle Loss and Joint Stability: The Issue That Doesnt Get Enough Attention This one doesnt get nearly as much coverage as it should, and for those with hypermobility its arguably the most significant concern of all
If youre experiencing severe nausea, vomiting, inability to keep food down, abdominal pain, or sudden vision loss, get medical help immediately
Lilly reported two analyses: the pre-specified in-study analysis, and a non-pre-specified on-treatment analysis excluding events occurring more than 35 days after discontinuation
27, 28, 29, 30, 31 Most importantly, prophylactic administration of antioxidants can ameliorate behavioral deficits in adulthood in animal models